Med-X is providing effective alternatives to conventional pesticides across residential ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
A message from Med-X Inc.
|
|
| Med-X is gearing up for a possible NASDAQ listing (ticker: MXRX). But the real opportunity is now – before public health adoption accelerates. 
In certain use cases, Med-X's all-natural pesticides have outperformed chemical brands in independent lab tests, delivering safer solutions without sacrificing results. Now, Med-X is approaching a major real-world validation catalyst: Florida Mosquito Control Districts are independently testing Nature-Cide as an adulticide, larvicide, and barrier treatment – with the goal of adding it to their official rotation. Florida has the most well-funded mosquito control districts in the United States and carries the highest responsibility for controlling mosquito-borne threats. These districts are known as leaders and innovators in Integrated Mosquito Management – meaning that when Florida adopts a solution, other regions often follow. And right now, these districts need better options. Public scrutiny over the chemical pesticides traditionally used in mosquito control is rising fast – especially around communities, schools, and waterways. Nature-Cide's plant-based approach offers a potential alternative that aligns with performance demands while reducing toxicity concerns. NASDAQ Ticker: MXRX Reserved
The Real Opportunity to Become a Shareholder Is Now! Med-X has earned national and international recognition for providing effective alternatives to conventional pesticides across residential, commercial, and agricultural sectors. Proudly produced in the USA under strict quality standards, Nature-Cide reflects their commitment to sustainable pest management innovation. With $6.4M in sales in just four years, expanding into 41 international markets, Med-X is getting ready for the next step... Simpler. Safer. More Effective Pesticides. Become a Med-X shareholder at $4 per share before their NASDAQ plans unfold. |
Disclosures This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com
|
|
|
| This is a paid advertisement provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not necessarily endorse this product nor is it responsible for the content of this advertisement. Schaeffer's makes no guarantee or warranty about what is advertised above.
To stop receiving these emails, unsubscribe.
Schaeffer's Investment Research
5151 Pfeiffer Road, Suite 450
Cincinnati, Ohio 45242 |
Post a Comment
Post a Comment